Original Article
Copyright ©2014 Baishideng Publishing Group Inc.
World J Gastrointest Endosc. May 16, 2014; 6(5): 176-185
Published online May 16, 2014. doi: 10.4253/wjge.v6.i5.176
Figure 2
Figure 2 Ghrelin-immunoreactive cells in a control subject (A), a patient with IBS-D (B), and a patient with IBS-C (C). IBS: Irritable bowel syndrome; IBS-D: Patients with diarrhea as the predominant syndrome; IBS-C: Patients with constipation as the predominant syndrome.